Updated on 9 January 2014
The challenge facing the world is enormous. So Mr Gates and oth- ers are fervently hoping daily that Asia's vaccine makers will further bring down the costs using more innovative techniques. That is the pressure now on companies like Serum Institute, Bharat Biotech, Biological E, and China National Biotec-to perform consistently and save the world from a major health catastrophe. The hepatitis B episode in China should just be an unwelcome footnote in the his- tory of Asia's vaccine companies at least in the New Year.